Navigation Links
China Nuvo Solar, Inc. Announces Corporate Name Change to SurgLine International, Inc.
Date:10/20/2011

WEST PALM BEACH, Fla., Oct. 20, 2011 /PRNewswire/ -- China Nuvo Solar Energy, Inc. (OTCQB: CNUV) today announced that The State of Nevada has approved the Company's requested corporate name change to SurgLine International, Inc. ("SI" or "Parent").  Majority shareholders recently approved and authorized the Board of Directors to change the Company's name. SurgLine, Inc. will remain as a wholly owned subsidiary of the Parent. As a result of the Nevada approval, the Company will file with the appropriate regulatory bodies the name change as well as a new ticker symbol to better reflect the Company's core business.  We will announce further details as the process and timing for the new name to be reflected in the markets as well as the new symbol as we go thru the regulatory process. Until then the Company will continue to trade under the symbol CNUV.

Mr. Tom Toland, CEO of SurgLine was quoted as saying "This was the logical next step in our corporate development. Changing the parent name to SurgLine International and having SurgLine, Inc. be the wholly owned operating subsidiary, paves the way for other business opportunities and reflects our current strategic plans to build long term shareholder value."

About SurgLine, Inc.

SurgLine (www.surgline.com) sources and distributes high quality FDA approved medical and surgical products at discount prices, thereby reducing or eliminating  the historical brand premium paid by healthcare providers including acute care hospitals, surgery centers, surgical hospitals, self insured employers and insurance companies. SurgLine offers high quality medical and surgical supplies and products at substantial savings utilizing stocking distributors and institutional buyers by sourcing products globally without the historical brand premium and industry markup.

About SurgLine International, Inc.

SurgLine International, Inc. is a holding company that in addition to SurgLine wholly owns Nuvo Solar Energy, Inc., a development stage company that owns unique patent pending solar and photovoltaic related technology.  The Company is also seeking other business opportunities.

This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on the Company's current expectations as to future events. However, the forward-looking events and circumstances discussed in this press release might not occur, and actual results could differ materially from those anticipated or implied in the forward-looking statements.

For Further Information Contact:
Henry Fong
561-514-9042


'/>"/>
SOURCE China Nuvo Solar Energy, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Perrigo Expands Infant Formula Distribution in China With Founder Group
2. Innocoll Enters Partnership With Pioneer Pharma in China for the Distribution of CollaGUARD
3. Boston Scientific Launches Promus Element™ Stent System In China
4. China Botanic Announces Results of Annual General Meeting
5. China Medical Technologies Announces the Approval of the Renewed High and New Technology Enterprise Status for a Major Subsidiary in China
6. China Sky One Medical, Inc. Elects Board Directors at its Annual Shareholders Meeting
7. China Medical Technologies Receives SFDA Approval for its PCR-based KRAS Assay for Colorectal Cancer Targeted Drug
8. China Medical Technologies Receives Two Patents Granted by the UKIPO and Notice of Allowance for Four Patent Applications from the USPTO
9. Peripheral Vascular Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017
10. VacChina 2011 International Conference Meets in Shanghai This November
11. China Biologic Announces Changes in Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2016)... 19, 2016 BioLineRx Ltd. (NASDAQ/TASE: ... the treatment of multiple cancer and hematological indications, will ... An abstract titled " Clinical response in relapsed/refractory AML ... by BL-8040, a potent CXCR4 antagonist; results of a ... presentation at the European Hematology Association 21st Congress, to ...
(Date:5/19/2016)... and CAMBRIDGE, Massachusetts , May 19, ... in the development of pharmaceuticals and diagnostics based on the ... a new office in Cambridge, MA ... US. The office is located at Kendall Square, ... industry, well-known as the global hub for transforming scientific insights ...
(Date:5/18/2016)... May 19, 2016 ... Research Report initially provides a basic overview ... and manufacturing technology, post which the report ... in the market. Complete report ... pages providing 8 company profiles and 98 ...
Breaking Medicine Technology:
(Date:5/23/2016)... ... 2016 , ... The Society for Women’s Health Research (SWHR) announced that its ... role. , “No one in Washington led the way to advance women’s health research ... MD, PhD. “We offer our deep gratitude to Phyllis for her passion and performance ...
(Date:5/23/2016)... , ... May 23, 2016 , ... ... on its Chesterfield, Missouri, campus, Standard Process Inc. awarded $6,000 in ... Siewert and Chloe Tillman. Each student is in her fifth trimester of classes ...
(Date:5/23/2016)... ... May 23, 2016 , ... Hadley ... worldwide for people who are blind or visually impaired, announces the election of ... President Charles E. Young. Hadley’s Board of Trustees retained Morris & Berger, a ...
(Date:5/23/2016)... ... May 23, 2016 , ... Four Circles Recovery Center, a leading treatment ... to announce the launch of its new extended care program, Fifth Circle. Available for ... Four Circles or another primary treatment program, Fifth Circle is designed to foster the ...
(Date:5/23/2016)... ... 23, 2016 , ... Bio-Optronics, Inc. is delighted to announce ... its recent and anticipated growth. , Max Elbaz was appointed as Vice President, ... segments. Max joined the Bio-Optronics team in March. His areas of expertise include ...
Breaking Medicine News(10 mins):